Acceptability of the Vaginal Diaphragm among Current Users

Perspectives on Sexual and Reproductive Health

Volumn 36, Issue 2, 2004, Pages 64-71

  Maher, Julie E ^a   Harvey, S Marie ^b   Bird, Sheryl Thorburn ^c   Stevens, Victor J ^d   Beckman, Linda J ^e  

^a OREGON DEPARTMENT OF HUMAN SERVICES   (United States)

^b UNIVERSITY OF OREGON   (United States)

^c OREGON STATE UNIVERSITY   (United States)

^d KAISER PERMANENTE   (United States)

^e ALLIANT INTERNATIONAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; AGE; DEMOGRAPHY; EMPLOYMENT; FEMALE; FEMALE CONTRACEPTIVE DEVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MANAGED CARE ORGANIZATION; MARRIAGE; MOTIVATION; NORMAL HUMAN; RACE; REVIEW; RISK FACTOR; SATISFACTION; SELF CONCEPT; SEXUALLY TRANSMITTED DISEASE; UNITED STATES;

ADULT; ATTITUDE TO HEALTH; CONTRACEPTION BEHAVIOR; CONTRACEPTIVE DEVICES, FEMALE; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MIDDLE AGED; NORTHWESTERN UNITED STATES; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; QUESTIONNAIRES; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; WOMEN'S HEALTH;

EID: 2342568382     PISSN: 15386341     EISSN: None     Source Type: Journal    
DOI: 10.1363/3606404     Document Type: Review

References (43)

1. Stone KM, Timyan J and Thomas EL, Barrier methods for the prevention of sexually transmitted diseases, in: Holmes KK et al., eds., Sexually Transmitted Diseases, New York: McGraw-Hill, 1999.
2. Amaro H, Love, sex and power: considering women's realities in HIV prevention, American Psychologist, 1995, 50(6):437-447; Amaro H and Raj A, On the margin: power and women's HIV risk reduction strategies, Sex Roles, 2000, 42(7-8):723-749; Blanc AK, The effect of power in sexual relationships on sexual and reproductive health: an examination of the evidence, Studies in Family Planning, 2001, 32(3):189-213; and Wingood GM and DiClemente RJ, Application of the theory of gender and power to examine HIV-related exposures, risk factors and effective interventions for women, Health Education and Behavior, 2000, 27(5):539-565.
3. Amaro H, Love, sex and power: considering women's realities in HIV prevention, American Psychologist, 1995, 50(6):437-447; Amaro H and Raj A, On the margin: power and women's HIV risk reduction strategies, Sex Roles, 2000, 42(7-8):723-749; Blanc AK, The effect of power in sexual relationships on sexual and reproductive health: an examination of the evidence, Studies in Family Planning, 2001, 32(3):189-213; and Wingood GM and DiClemente RJ, Application of the theory of gender and power to examine HIV-related exposures, risk factors and effective interventions for women, Health Education and Behavior, 2000, 27(5):539-565.
4. Amaro H, Love, sex and power: considering women's realities in HIV prevention, American Psychologist, 1995, 50(6):437-447; Amaro H and Raj A, On the margin: power and women's HIV risk reduction strategies, Sex Roles, 2000, 42(7-8):723-749; Blanc AK, The effect of power in sexual relationships on sexual and reproductive health: an examination of the evidence, Studies in Family Planning, 2001, 32(3):189-213; and Wingood GM and DiClemente RJ, Application of the theory of gender and power to examine HIV-related exposures, risk factors and effective interventions for women, Health Education and Behavior, 2000, 27(5):539-565.
5. Amaro H, Love, sex and power: considering women's realities in HIV prevention, American Psychologist, 1995, 50(6):437-447; Amaro H and Raj A, On the margin: power and women's HIV risk reduction strategies, Sex Roles, 2000, 42(7-8):723-749; Blanc AK, The effect of power in sexual relationships on sexual and reproductive health: an examination of the evidence, Studies in Family Planning, 2001, 32(3):189-213; and Wingood GM and DiClemente RJ, Application of the theory of gender and power to examine HIV-related exposures, risk factors and effective interventions for women, Health Education and Behavior, 2000, 27(5):539-565.
6. Stein Z, HIV prevention: an update on the status of methods women can use, American Journal of Public Health, 1993, 83(10):1379-1382; Stein Z, More on women and the prevention of HIV infection, editorial, American Journal of Public Health, 1995, 85(11):1485-1487; and Stein Z and Susser M, Prevention of HIV, other sexually transmitted diseases and unwanted pregnancy-testing physical barriers available to women, annotation, American Journal of Public Health, 1998, 88(6):872-874.
7. Stein Z, HIV prevention: an update on the status of methods women can use, American Journal of Public Health, 1993, 83(10):1379-1382; Stein Z, More on women and the prevention of HIV infection, editorial, American Journal of Public Health, 1995, 85(11):1485-1487; and Stein Z and Susser M, Prevention of HIV, other sexually transmitted diseases and unwanted pregnancy-testing physical barriers available to women, annotation, American Journal of Public Health, 1998, 88(6):872-874.
8. Stein Z, HIV prevention: an update on the status of methods women can use, American Journal of Public Health, 1993, 83(10):1379-1382; Stein Z, More on women and the prevention of HIV infection, editorial, American Journal of Public Health, 1995, 85(11):1485-1487; and Stein Z and Susser M, Prevention of HIV, other sexually transmitted diseases and unwanted pregnancy-testing physical barriers available to women, annotation, American Journal of Public Health, 1998, 88(6):872-874.
9. Moench TR et al., Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices, AIDS, 2001(15): 1595-1602.
10. Berger GS, Keith L and Moss W, Prevalence of gonorrhea among women using various methods of contraception, British Journal of Venereal Disease, 1975, 51(5):307-309; Quinn RW and O'Reilly KR, Contraceptive practices of women attending the sexually transmitted disease clinic in Nashville, Tennessee, Sexually Transmitted Diseases, 1985, 12(3):99-102; Magder LS et al., Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic, American Journal of Epidemiology, 1988, 128(2):298-308; Rosenberg MJ et al., Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms, American Journal of Public Health, 1992, 82(5):669-674; Austin H et al., A case-control study of spermicides and gonorrhea, Journal of the American Medical Association, 1984, 251(21):2822-2824; Becker TM et al., Contraceptive and reproductive risks for cervical dysplasia in Southwestern Hispanic and non-Hispanic white women, International Journal of Epidemiology, 1994, 23(5):913-922; Kjaer SK et al., Risk factors for cervical human papillomavirus and herpes simplex virus infections in Greenland and Denmark: a population-based study, American Journal of Epidemiology, 1990, 131(4):669-682; Wølner-Hanssen P et al., Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use, Journal of the American Medical Association, 1990, 263(1):54-59; and Kelaghan J et al., Barrier-method contraceptives and pelvic inflammatory disease, Journal of the American Medical Association, 1982, 248(2):184-187.
11. Berger GS, Keith L and Moss W, Prevalence of gonorrhea among women using various methods of contraception, British Journal of Venereal Disease, 1975, 51(5):307-309; Quinn RW and O'Reilly KR, Contraceptive practices of women attending the sexually transmitted disease clinic in Nashville, Tennessee, Sexually Transmitted Diseases, 1985, 12(3):99-102; Magder LS et al., Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic, American Journal of Epidemiology, 1988, 128(2):298-308; Rosenberg MJ et al., Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms, American Journal of Public Health, 1992, 82(5):669-674; Austin H et al., A case-control study of spermicides and gonorrhea, Journal of the American Medical Association, 1984, 251(21):2822-2824; Becker TM et al., Contraceptive and reproductive risks for cervical dysplasia in Southwestern Hispanic and non-Hispanic white women, International Journal of Epidemiology, 1994, 23(5):913-922; Kjaer SK et al., Risk factors for cervical human papillomavirus and herpes simplex virus infections in Greenland and Denmark: a population-based study, American Journal of Epidemiology, 1990, 131(4):669-682; Wølner-Hanssen P et al., Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use, Journal of the American Medical Association, 1990, 263(1):54-59; and Kelaghan J et al., Barrier-method contraceptives and pelvic inflammatory disease, Journal of the American Medical Association, 1982, 248(2):184-187.
12. Berger GS, Keith L and Moss W, Prevalence of gonorrhea among women using various methods of contraception, British Journal of Venereal Disease, 1975, 51(5):307-309; Quinn RW and O'Reilly KR, Contraceptive practices of women attending the sexually transmitted disease clinic in Nashville, Tennessee, Sexually Transmitted Diseases, 1985, 12(3):99-102; Magder LS et al., Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic, American Journal of Epidemiology, 1988, 128(2):298-308; Rosenberg MJ et al., Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms, American Journal of Public Health, 1992, 82(5):669-674; Austin H et al., A case-control study of spermicides and gonorrhea, Journal of the American Medical Association, 1984, 251(21):2822-2824; Becker TM et al., Contraceptive and reproductive risks for cervical dysplasia in Southwestern Hispanic and non-Hispanic white women, International Journal of Epidemiology, 1994, 23(5):913-922; Kjaer SK et al., Risk factors for cervical human papillomavirus and herpes simplex virus infections in Greenland and Denmark: a population-based study, American Journal of Epidemiology, 1990, 131(4):669-682; Wølner-Hanssen P et al., Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use, Journal of the American Medical Association, 1990, 263(1):54-59; and Kelaghan J et al., Barrier-method contraceptives and pelvic inflammatory disease, Journal of the American Medical Association, 1982, 248(2):184-187.
13. Berger GS, Keith L and Moss W, Prevalence of gonorrhea among women using various methods of contraception, British Journal of Venereal Disease, 1975, 51(5):307-309; Quinn RW and O'Reilly KR, Contraceptive practices of women attending the sexually transmitted disease clinic in Nashville, Tennessee, Sexually Transmitted Diseases, 1985, 12(3):99-102; Magder LS et al., Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic, American Journal of Epidemiology, 1988, 128(2):298-308; Rosenberg MJ et al., Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms, American Journal of Public Health, 1992, 82(5):669-674; Austin H et al., A case-control study of spermicides and gonorrhea, Journal of the American Medical Association, 1984, 251(21):2822-2824; Becker TM et al., Contraceptive and reproductive risks for cervical dysplasia in Southwestern Hispanic and non-Hispanic white women, International Journal of Epidemiology, 1994, 23(5):913-922; Kjaer SK et al., Risk factors for cervical human papillomavirus and herpes simplex virus infections in Greenland and Denmark: a population-based study, American Journal of Epidemiology, 1990, 131(4):669-682; Wølner-Hanssen P et al., Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use, Journal of the American Medical Association, 1990, 263(1):54-59; and Kelaghan J et al., Barrier-method contraceptives and pelvic inflammatory disease, Journal of the American Medical Association, 1982, 248(2):184-187.
14. Berger GS, Keith L and Moss W, Prevalence of gonorrhea among women using various methods of contraception, British Journal of Venereal Disease, 1975, 51(5):307-309; Quinn RW and O'Reilly KR, Contraceptive practices of women attending the sexually transmitted disease clinic in Nashville, Tennessee, Sexually Transmitted Diseases, 1985, 12(3):99-102; Magder LS et al., Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic, American Journal of Epidemiology, 1988, 128(2):298-308; Rosenberg MJ et al., Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms, American Journal of Public Health, 1992, 82(5):669-674; Austin H et al., A case-control study of spermicides and gonorrhea, Journal of the American Medical Association, 1984, 251(21):2822-2824; Becker TM et al., Contraceptive and reproductive risks for cervical dysplasia in Southwestern Hispanic and non-Hispanic white women, International Journal of Epidemiology, 1994, 23(5):913-922; Kjaer SK et al., Risk factors for cervical human papillomavirus and herpes simplex virus infections in Greenland and Denmark: a population-based study, American Journal of Epidemiology, 1990, 131(4):669-682; Wølner-Hanssen P et al., Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use, Journal of the American Medical Association, 1990, 263(1):54-59; and Kelaghan J et al., Barrier-method contraceptives and pelvic inflammatory disease, Journal of the American Medical Association, 1982, 248(2):184-187.
15. Berger GS, Keith L and Moss W, Prevalence of gonorrhea among women using various methods of contraception, British Journal of Venereal Disease, 1975, 51(5):307-309; Quinn RW and O'Reilly KR, Contraceptive practices of women attending the sexually transmitted disease clinic in Nashville, Tennessee, Sexually Transmitted Diseases, 1985, 12(3):99-102; Magder LS et al., Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic, American Journal of Epidemiology, 1988, 128(2):298-308; Rosenberg MJ et al., Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms, American Journal of Public Health, 1992, 82(5):669-674; Austin H et al., A case-control study of spermicides and gonorrhea, Journal of the American Medical Association, 1984, 251(21):2822-2824; Becker TM et al., Contraceptive and reproductive risks for cervical dysplasia in Southwestern Hispanic and non-Hispanic white women, International Journal of Epidemiology, 1994, 23(5):913-922; Kjaer SK et al., Risk factors for cervical human papillomavirus and herpes simplex virus infections in Greenland and Denmark: a population-based study, American Journal of Epidemiology, 1990, 131(4):669-682; Wølner-Hanssen P et al., Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use, Journal of the American Medical Association, 1990, 263(1):54-59; and Kelaghan J et al., Barrier-method contraceptives and pelvic inflammatory disease, Journal of the American Medical Association, 1982, 248(2):184-187.
16. Berger GS, Keith L and Moss W, Prevalence of gonorrhea among women using various methods of contraception, British Journal of Venereal Disease, 1975, 51(5):307-309; Quinn RW and O'Reilly KR, Contraceptive practices of women attending the sexually transmitted disease clinic in Nashville, Tennessee, Sexually Transmitted Diseases, 1985, 12(3):99-102; Magder LS et al., Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic, American Journal of Epidemiology, 1988, 128(2):298-308; Rosenberg MJ et al., Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms, American Journal of Public Health, 1992, 82(5):669-674; Austin H et al., A case-control study of spermicides and gonorrhea, Journal of the American Medical Association, 1984, 251(21):2822-2824; Becker TM et al., Contraceptive and reproductive risks for cervical dysplasia in Southwestern Hispanic and non-Hispanic white women, International Journal of Epidemiology, 1994, 23(5):913-922; Kjaer SK et al., Risk factors for cervical human papillomavirus and herpes simplex virus infections in Greenland and Denmark: a population-based study, American Journal of Epidemiology, 1990, 131(4):669-682; Wølner-Hanssen P et al., Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use, Journal of the American Medical Association, 1990, 263(1):54-59; and Kelaghan J et al., Barrier-method contraceptives and pelvic inflammatory disease, Journal of the American Medical Association, 1982, 248(2):184-187.
17. Berger GS, Keith L and Moss W, Prevalence of gonorrhea among women using various methods of contraception, British Journal of Venereal Disease, 1975, 51(5):307-309; Quinn RW and O'Reilly KR, Contraceptive practices of women attending the sexually transmitted disease clinic in Nashville, Tennessee, Sexually Transmitted Diseases, 1985, 12(3):99-102; Magder LS et al., Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic, American Journal of Epidemiology, 1988, 128(2):298-308; Rosenberg MJ et al., Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms, American Journal of Public Health, 1992, 82(5):669-674; Austin H et al., A case-control study of spermicides and gonorrhea, Journal of the American Medical Association, 1984, 251(21):2822-2824; Becker TM et al., Contraceptive and reproductive risks for cervical dysplasia in Southwestern Hispanic and non-Hispanic white women, International Journal of Epidemiology, 1994, 23(5):913-922; Kjaer SK et al., Risk factors for cervical human papillomavirus and herpes simplex virus infections in Greenland and Denmark: a population-based study, American Journal of Epidemiology, 1990, 131(4):669-682; Wølner-Hanssen P et al., Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use, Journal of the American Medical Association, 1990, 263(1):54-59; and Kelaghan J et al., Barrier-method contraceptives and pelvic inflammatory disease, Journal of the American Medical Association, 1982, 248(2):184-187.
18. Berger GS, Keith L and Moss W, Prevalence of gonorrhea among women using various methods of contraception, British Journal of Venereal Disease, 1975, 51(5):307-309; Quinn RW and O'Reilly KR, Contraceptive practices of women attending the sexually transmitted disease clinic in Nashville, Tennessee, Sexually Transmitted Diseases, 1985, 12(3):99-102; Magder LS et al., Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic, American Journal of Epidemiology, 1988, 128(2):298-308; Rosenberg MJ et al., Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms, American Journal of Public Health, 1992, 82(5):669-674; Austin H et al., A case-control study of spermicides and gonorrhea, Journal of the American Medical Association, 1984, 251(21):2822-2824; Becker TM et al., Contraceptive and reproductive risks for cervical dysplasia in Southwestern Hispanic and non-Hispanic white women, International Journal of Epidemiology, 1994, 23(5):913-922; Kjaer SK et al., Risk factors for cervical human papillomavirus and herpes simplex virus infections in Greenland and Denmark: a population-based study, American Journal of Epidemiology, 1990, 131(4):669-682; Wølner-Hanssen P et al., Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use, Journal of the American Medical Association, 1990, 263(1):54-59; and Kelaghan J et al., Barrier-method contraceptives and pelvic inflammatory disease, Journal of the American Medical Association, 1982, 248(2):184-187.
19. Moss GB et al., HIV DNA in urethral secretions in men: association with gonococcal urethritis in CD4 depletion, Journal of Infectious Diseases, 1995, 5(172):1469-1474; Hoffman I et al., Effects of urethritis therapy on the concentration of HIV-1 in seminal plasma, paper presented at the XI International Conference on AIDS, Vancouver, Canada, July 7-12, 1996; and Laga M et al., Nonulcerative sexually transmitted diseases as risk factors of HIV-1 transmission in women: results from a cohort study, AIDS, 1993, 3(7):95-102.
20. Moss GB et al., HIV DNA in urethral secretions in men: association with gonococcal urethritis in CD4 depletion, Journal of Infectious Diseases, 1995, 5(172):1469-1474; Hoffman I et al., Effects of urethritis therapy on the concentration of HIV-1 in seminal plasma, paper presented at the XI International Conference on AIDS, Vancouver, Canada, July 7-12, 1996; and Laga M et al., Nonulcerative sexually transmitted diseases as risk factors of HIV-1 transmission in women: results from a cohort study, AIDS, 1993, 3(7):95-102.
21. Moss GB et al., HIV DNA in urethral secretions in men: association with gonococcal urethritis in CD4 depletion, Journal of Infectious Diseases, 1995, 5(172):1469-1474; Hoffman I et al., Effects of urethritis therapy on the concentration of HIV-1 in seminal plasma, paper presented at the XI International Conference on AIDS, Vancouver, Canada, July 7-12, 1996; and Laga M et al., Nonulcerative sexually transmitted diseases as risk factors of HIV-1 transmission in women: results from a cohort study, AIDS, 1993, 3(7):95-102.
22. Piccinino LJ and Mosher WD, Trends in contraceptive use in the United States, Family Planning Perspectives, 1998, 30(1):4-10 & 46.
23. Mantell JE et al., Family planning providers' perspectives on dual protection, Perspectives on Sexual and Reproductive Health, 2003, 35(2): 71-78.
24. Schwartz JL and Gabelnick HL, Current contraceptive research, review, Perspectives on Sexual and Reproductive Health 2002, 34(6):310-316.
25. DiGiacomo T et al., Acceptability of the diaphragm among low-income women in São Paulo, Brazil, International Family Planning Perspectives, 1995, 21(3):114-118; Ortayli N et al., Is the diaphragm a viable option for women in Turkey? International Family Planning Perspectives, 2000, 26(1):36-42; Ravindran TKS and Rao SS, Is the diaphragm a suitable method of contraception for low-income women: a user perspectives study, Madras, India, in: Ravindran TKS, Berer M and Cottingham J, eds., Beyond Acceptability: Users' Perspectives on Contraception, London: Reproductive Health Matters, 1997, pp. 78-88; Bulut A et al., Assessing the acceptability, service delivery requirements and use-effectiveness of the diaphragm in Colombia, Philippines, and Turkey, Contraception, 2001, 63(5):267-275; and Mauck C et al., A comparative study of the safety and efficacy of FemCap, a new vaginal barrier contraceptive, and the Ortho All-Flex diaphragm: The FemCap Investigators' Group, Contraception, 1999, 60(2):71-80.
26. DiGiacomo T et al., Acceptability of the diaphragm among low-income women in São Paulo, Brazil, International Family Planning Perspectives, 1995, 21(3):114-118; Ortayli N et al., Is the diaphragm a viable option for women in Turkey? International Family Planning Perspectives, 2000, 26(1):36-42; Ravindran TKS and Rao SS, Is the diaphragm a suitable method of contraception for low-income women: a user perspectives study, Madras, India, in: Ravindran TKS, Berer M and Cottingham J, eds., Beyond Acceptability: Users' Perspectives on Contraception, London: Reproductive Health Matters, 1997, pp. 78-88; Bulut A et al., Assessing the acceptability, service delivery requirements and use-effectiveness of the diaphragm in Colombia, Philippines, and Turkey, Contraception, 2001, 63(5):267-275; and Mauck C et al., A comparative study of the safety and efficacy of FemCap, a new vaginal barrier contraceptive, and the Ortho All-Flex diaphragm: The FemCap Investigators' Group, Contraception, 1999, 60(2):71-80.
27. DiGiacomo T et al., Acceptability of the diaphragm among low-income women in São Paulo, Brazil, International Family Planning Perspectives, 1995, 21(3):114-118; Ortayli N et al., Is the diaphragm a viable option for women in Turkey? International Family Planning Perspectives, 2000, 26(1):36-42; Ravindran TKS and Rao SS, Is the diaphragm a suitable method of contraception for low-income women: a user perspectives study, Madras, India, in: Ravindran TKS, Berer M and Cottingham J, eds., Beyond Acceptability: Users' Perspectives on Contraception, London: Reproductive Health Matters, 1997, pp. 78-88; Bulut A et al., Assessing the acceptability, service delivery requirements and use-effectiveness of the diaphragm in Colombia, Philippines, and Turkey, Contraception, 2001, 63(5):267-275; and Mauck C et al., A comparative study of the safety and efficacy of FemCap, a new vaginal barrier contraceptive, and the Ortho All-Flex diaphragm: The FemCap Investigators' Group, Contraception, 1999, 60(2):71-80.
28. DiGiacomo T et al., Acceptability of the diaphragm among low-income women in São Paulo, Brazil, International Family Planning Perspectives, 1995, 21(3):114-118; Ortayli N et al., Is the diaphragm a viable option for women in Turkey? International Family Planning Perspectives, 2000, 26(1):36-42; Ravindran TKS and Rao SS, Is the diaphragm a suitable method of contraception for low-income women: a user perspectives study, Madras, India, in: Ravindran TKS, Berer M and Cottingham J, eds., Beyond Acceptability: Users' Perspectives on Contraception, London: Reproductive Health Matters, 1997, pp. 78-88; Bulut A et al., Assessing the acceptability, service delivery requirements and use-effectiveness of the diaphragm in Colombia, Philippines, and Turkey, Contraception, 2001, 63(5):267-275; and Mauck C et al., A comparative study of the safety and efficacy of FemCap, a new vaginal barrier contraceptive, and the Ortho All-Flex diaphragm: The FemCap Investigators' Group, Contraception, 1999, 60(2):71-80.
29. DiGiacomo T et al., Acceptability of the diaphragm among low-income women in São Paulo, Brazil, International Family Planning Perspectives, 1995, 21(3):114-118; Ortayli N et al., Is the diaphragm a viable option for women in Turkey? International Family Planning Perspectives, 2000, 26(1):36-42; Ravindran TKS and Rao SS, Is the diaphragm a suitable method of contraception for low-income women: a user perspectives study, Madras, India, in: Ravindran TKS, Berer M and Cottingham J, eds., Beyond Acceptability: Users' Perspectives on Contraception, London: Reproductive Health Matters, 1997, pp. 78-88; Bulut A et al., Assessing the acceptability, service delivery requirements and use-effectiveness of the diaphragm in Colombia, Philippines, and Turkey, Contraception, 2001, 63(5):267-275; and Mauck C et al., A comparative study of the safety and efficacy of FemCap, a new vaginal barrier contraceptive, and the Ortho All-Flex diaphragm: The FemCap Investigators' Group, Contraception, 1999, 60(2):71-80.
30. Elias CJ and Coggins C, Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: where have we been? where are we going? Journal of Women's Health and Gender-Based Medicine, 2001, 10(2):163-173.
31. Harvey SM et al., Who continues using the diaphragm and who doesn't: implications for the acceptability of female-controlled HIV prevention methods, Women's Health Issues, 2003, 13(5):185-193.
32. Brafford LJ and Beck KH, Development and validation of a condom self-efficacy scale for college students, Journal of American College Health, 1991, 39(5):219-225.
33. Harvey SM et al., 2003, op. cit. (see reference 12).
34. Beckman LJ, Harvey SM and Murray J, Dimensions of the multidimensional Contraceptive Attributes Questionnaire (CAQ), Psychology of Women Quarterly, 1992, 16(2):243-259.
35. Harvey SM et al., 2003, op. cit. (see reference 12).
36. I b i d.
37. Severy LJ and Newcomer S, Critical issues in contraceptive and STI acceptability research: the impact of new technologies on intimate behavior, Journal of Social Issues, 2004 (forthcoming).
38. Bird ST et al., Acceptability of an existing, female-controlled contraceptive method that could potentially protect against HIV: a comparison of diaphragm users and other method users, Women's Health Issues, 2004 (forthcoming).
39. Bulut A et al., 2001, op. cit. (see reference 10).
40. Grady WR, Billy JO and Klepinger DH, Contraceptive method switching in the United States, Perspectives on Sexual and Reproductive Health, 2002, 34(3):135-145.
41. Severy LJ and Silver SE, Two reasonable people: joint decision-making in fertility regulation, in: Severy LJ, ed., Advances in Population: Psychosocial Perspectives, Vol. 1, London: Jessica Kingsley Publishers, 1993, pp. 207-227.
42. Branch MR et al., A new look at an old method: exploring diaphragm use is a potential HIV prevention strategy among high risk women, paper presented at the annual meeting of the American Public Health Association, San Francisco, Nov. 15-19, 2003.
43. Tone A, Devices and Desires: A History of Contraceptives in America, New York: Hill and Wang, 2001, pp. 117-149.